Yali Shen

976 total citations
67 papers, 637 citations indexed

About

Yali Shen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yali Shen has authored 67 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Yali Shen's work include Gastric Cancer Management and Outcomes (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Metastasis and carcinoma case studies (7 papers). Yali Shen is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Metastasis and carcinoma case studies (7 papers). Yali Shen collaborates with scholars based in China, United States and Spain. Yali Shen's co-authors include Renming Zhong, Sen Bai, Qingfeng Xu, Xiaoqin Jiang, Ying Liu, Hui Ren, Tao Zhang, Ji Ma, Feng Bi and Xin Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yali Shen

62 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yali Shen China	12	189	174	150	131	112	67	637
László Thurzó Hungary	14	110 0.6×	118 0.7×	131 0.9×	126 1.0×	82 0.7×	45	613
Sven Wenske United States	21	188 1.0×	68 0.4×	684 4.6×	92 0.7×	283 2.5×	41	1.2k
Benoîte Méry France	12	149 0.8×	34 0.2×	147 1.0×	79 0.6×	66 0.6×	68	552
Zhaozhi Yang China	18	209 1.1×	191 1.1×	273 1.8×	151 1.2×	132 1.2×	57	986
Rozelle Harvie Australia	15	261 1.4×	37 0.2×	298 2.0×	102 0.8×	83 0.7×	28	806
Alexandra Thomas United States	14	206 1.1×	35 0.2×	82 0.5×	25 0.2×	66 0.6×	27	595
Yaping Xu China	19	317 1.7×	51 0.3×	495 3.3×	143 1.1×	233 2.1×	63	1.1k
Yoshihiro Fujii Japan	14	305 1.6×	19 0.1×	167 1.1×	69 0.5×	55 0.5×	34	667
Irmgard Helmbold Germany	11	332 1.8×	89 0.5×	155 1.0×	425 3.2×	62 0.6×	12	761
T. Smudzin United States	15	173 0.9×	153 0.9×	563 3.8×	516 3.9×	102 0.9×	34	1.4k

Countries citing papers authored by Yali Shen

Since Specialization

Citations

This map shows the geographic impact of Yali Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Shen more than expected).

Fields of papers citing papers by Yali Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Shen. The network helps show where Yali Shen may publish in the future.

Co-authorship network of co-authors of Yali Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yali Shen. A scholar is included among the top collaborators of Yali Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali Shen. Yali Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xia, et al.. (2024). Energy-guided diffusion model for CBCT-to-CT synthesis. Computerized Medical Imaging and Graphics. 113. 102344–102344. 5 indexed citations

Wen, Feng, Tianhai Lin, Peng Zhang, et al.. (2024). Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial. BMJ Open. 14(1). e076663–e076663. 1 indexed citations

Wen, Feng, et al.. (2024). Preliminary results from a multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).. Journal of Clinical Oncology. 42(16_suppl). e16595–e16595. 2 indexed citations

Liu, Ping, Yi Xiao, Wenjian Meng, et al.. (2024). Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial.. Journal of Clinical Oncology. 42(17_suppl). LBA3511–LBA3511. 3 indexed citations

Wen, Feng, Tianhai Lin, Peng Zhang, & Yali Shen. (2024). RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03). Frontiers in Oncology. 13. 1233196–1233196. 7 indexed citations

Lin, Tianhai, et al.. (2023). A phase 2, open-label study of neoadjuvant chemotherapy plus tislelizumab followed by radiotherapy-based, bladder-preserving treatment for high risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).. Journal of Clinical Oncology. 41(6_suppl). 516–516. 1 indexed citations

Zhou, Min, et al.. (2022). Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements. BMC Cancer. 22(1). 859–859. 8 indexed citations

Chen, Hao, Jing Wang, Ling Xie, et al.. (2021). Correlation between serum cartilage oligomeric matrix protein and major adverse cardiovascular events within 30 days in patients with acute coronary syndrome. Annals of Translational Medicine. 9(4). 353–353. 2 indexed citations

Zhou, Min, et al.. (2021). The long-term outcome and risk factors for precursor B cell acute lymphoblastic leukemia without specific fusion genes in Chinese children: experiences from multiple centers. Bosnian Journal of Basic Medical Sciences. 22(2). 238–246. 3 indexed citations

10.

Zhu, Yueting, Xin‐Zu Chen, Ye Chen, et al.. (2020). Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer. Frontiers in Oncology. 10. 570268–570268. 3 indexed citations

11.

Shen, Yali, Xiaobing Li, Liang Li, et al.. (2017). Fewer beams and segments result in a shorter delivery time and a better quality intensity-modulated radiotherapy plan in gastric cancer. Iranian Journal of radiation research. 15(3). 295–299. 1 indexed citations

12.

Shen, Yali, Nan Feng, Mei Li, et al.. (2016). Pharmacokinetic Properties of Intravenous Ibuprofen in Healthy Chinese Volunteers. Clinical Drug Investigation. 36(12). 1051–1058. 6 indexed citations

13.

Liu, Yan, et al.. (2015). A novel robust quantitative Förster resonance energy transfer assay for protease SENP2 kinetics determination against its all natural substrates. Molecular BioSystems. 11(12). 3407–3414. 3 indexed citations

14.

Wang, Xin, Min Yu, Jin Wang, et al.. (2015). An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography. Molecular and Clinical Oncology. 4(2). 271–277. 10 indexed citations

15.

Siefker‐Radtke, Arlene O., Colin P. Dinney, Yali Shen, et al.. (2013). Re: A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: Final results. The Journal of Urology. 190(6).

16.

Fan, Yu, Lu Li, Zhihao Wu, et al.. (2012). nm23‐H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in mice. Thoracic Cancer. 4(1). 41–52. 12 indexed citations

17.

Zhu, Hong, Yaqin Zhao, Xin Wang, et al.. (2012). Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma. Oncology Letters. 4(3). 471–476. 4 indexed citations

18.

Shen, Yali, et al.. (2010). [Growth and differentiation effect on HL60 cells by adenovirus-mediated exogenous wnt5a gene modification on human bone marrow mesenchymal stem cells].. PubMed. 41(6). 931–5. 1 indexed citations

19.

Wang, Xin, Yongsheng Wang, Meng Qiu, et al.. (2010). Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen). Medical Oncology. 28(S1). 274–279. 12 indexed citations

20.

Hou, Min, Meng Qiu, Yang Yu, et al.. (2010). Antiemetic activity of megestrol acetate in patients receiving chemotherapy. Supportive Care in Cancer. 19(5). 667–673. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact